Published in Gene Therapy Weekly, July 1st, 2004
"The tyrosine kinase activity of p210(BCR-ABL) is essential to its leukemogenic potential, but the role of other functional domains in primary human hematopoietic cells has not been previously investigated. Here we show that infection of normal human CD34+ cord blood (CB) cells with a retroviral vector encoding p210(BCR-ABL) rapidly activates a factor-independent phenotype and autocrine interleukin-3/granulocyte colony-stimulating factor/erythropoietin production in the transduced cells," researchers in Canada report.
"These changes," wrote Y. Chalandon and coworkers, "are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly